Advisory Commission on Childhood Vaccines; Notice of Meeting, 28062-28063 [E7-9533]
Download as PDF
<![CDATA[
28062
Federal Register / Vol. 72, No. 96 / Friday, May 18, 2007 / Notices
This cadre of health care experts can
serve as a ‘‘frontline’’ source of
information to NHSC senior level
management. NAC is committed to
effectively implementing its mandate to
advise the Secretary and, by
designation, the Administrator, HRSA.
The NAC:
• Serves as a forum to identify the
priorities for the NHSC and bring
forward and anticipate future program
issues and concerns through ongoing
communication with program staff,
professional organizations, communities
and program participants;
• Functions as a sounding board for
proposed policy changes by utilizing the
varying levels of expertise represented
on the Council to advise on specific
program areas; and
• Develops and distributes White
Papers and briefs that clearly state
issues and/or concerns relating to the
NHSC with specific recommendations
for necessary policy revisions.
Interested persons may nominate one
or more qualified persons for
membership on NAC. Nominations shall
state that the nominee is willing to serve
as a member of NAC and appears to
have no conflicts of interest that would
preclude the NAC membership.
Potential candidates will be asked to
provide detailed information concerning
consultancies, research grants, or
contracts to permit evaluation of
possible sources of conflicts of interest.
A curriculum vitae or resume should be
submitted with the nomination.
The Department of Health and Human
Services has special interest in assuring
that women, minority groups, and the
physically disabled are adequately
represented on advisory committees;
and therefore, extends particular
encouragement to nominations for
appropriately qualified female,
minority, or disabled candidates.
SUMMARY: The Health Resources and
Services Administration (HRSA) is
updating income levels used to identify
a ‘‘low income family’’ for the purpose
of determining eligibility for programs
that provide health professions and
nursing training for individuals from
disadvantaged backgrounds. These
various programs are included in Titles
III, VII and VIII of the Public Health
Service (PHS) Act.
The Department periodically
publishes in the Federal Register lowincome levels used to determine
eligibility for grants and cooperative
agreements to institutions providing
training for (1) disadvantaged
individuals, (2) individuals from
disadvantaged backgrounds, or (3)
individuals from ‘‘low-income’’
families.
Dated: May 11, 2007.
Caroline Lewis,
Associate Administrator for Management.
[FR Doc. E7–9545 Filed 5–17–07; 8:45 am]
The Secretary defines a ‘‘low income
family’’ for programs included in Titles
III, VII and VIII of the Public Health
Service Act as a family having an
annual income that does not exceed 200
percent of the Department’s poverty
guidelines. A ‘‘family’’ is a group of two
or more individuals related by birth,
marriage, or adoption who live together
or an individual who is not living with
any relatives. Most HRSA programs use
the income of the student’s parents to
compute low income status. However, a
few programs, depending upon the
legislative intent of the program,
programmatic purpose of the low
income level, as well as the age and
circumstances of the average
participant, will use the student’s family
income, as long as he or she is not listed
as a dependent upon the parents’ tax
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
pwalker on PROD1PC71 with NOTICES
Health Resources and Services
Administration
’’Low Income Levels’’ Used for Various
Health Professions and Nursing
Programs Included in Titles III, VII and
VIII of the Public Health Service Act
Health Resources and Services
Administration, HHS.
ACTION: Notice.
AGENCY:
VerDate Aug<31>2005
17:06 May 17, 2007
Jkt 211001
The
various health professions and nursing
grant and cooperative agreement
programs that use the low income levels
to determine whether an individual is
from an economically disadvantaged
background in making eligibility and
funding determinations generally make
awards to: Accredited schools of
medicine, osteopathic medicine, public
health, dentistry, veterinary medicine,
optometry, pharmacy, allied health
podiatric medicine, nursing,
chiropractic, public or private nonprofit
schools which offer graduate programs
in behavioral health and mental health
practice, and other public or private
nonprofit health or education entities to
assist the disadvantaged to enter and
graduate from health professions and
nursing schools. Some programs
provide for the repayment of health
professions or nursing education loans
for disadvantaged students.
SUPPLEMENTARY INFORMATION:
Low-Income Levels
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
form. Each program will announce the
rationale and choice of methodology for
determining low income levels in their
program guidance. The Department’s
poverty guidelines are based on poverty
thresholds published by the U.S. Bureau
of the Census, adjusted annually for
changes in the Consumer Price Index.
The Secretary annually adjusts the
low income levels based on the
Department’s poverty guidelines and
makes them available to persons
responsible for administering the
applicable programs. The income
figures below have been updated to
reflect increases in the Consumer Price
Index through December 31, 2006.
Size of parents’ family*
1
2
3
4
5
6
7
8
Income level**
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
$20,420
27,380
34,340
41,300
48,260
55,220
62,180
69,140
* Includes only dependents listed on Federal
income tax forms. Some programs will use the
student’s family rather than his or her parents’
family.
** Adjusted gross income for calendar year
2006.
Dated: May 10, 2007.
Elizabeth M. Duke,
Administrator.
[FR Doc. E7–9548 Filed 5–17–07; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Commission on Childhood
Vaccines; Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Public Law 92–463), notice is hereby
given of the following meeting:
Name: Advisory Commission on
Childhood Vaccines (ACCV).
Date And Time: June 7, 2007, 1 p.m.—
5 p.m., EST.
Place: (Audio Conference Call).
The ACCV will meet on Thursday,
June 7, from 1 p.m. to 5 p.m., (EST). The
public can join the meeting via audio
conference call by dialing 1–888–324–
8527 on June 7 and providing the
following information:
Leader’s Name: Dr. Geoffrey Evans.
Password: ACCV.
Agenda: The agenda items for the
June meeting will include, but are not
limited to: a summary of the ‘‘Vaccine
E:\FR\FM\18MYN1.SGM
18MYN1
Federal Register / Vol. 72, No. 96 / Friday, May 18, 2007 / Notices
Safety Evaluation: Post-Marketing
Surveillance’’ conference; and updates
from the Division of Vaccine Injury
Compensation (DVIC), Department of
Justice, National Vaccine Program
Office, Immunization Safety Office
(Centers for Disease Control and
Prevention), National Institute of
Allergy and Infectious Diseases
(National Institutes of Health), and
Center for Biologics and Evaluation
Research (Food and Drug
Administration). Agenda items are
subject to change as priorities dictate.
Public Comments: Persons interested
in providing an oral presentation should
submit a written request, along with a
copy of their presentation to: LCDR
Delia Jones, Principal Staff Liaison,
DVIC, Healthcare Systems Bureau
(HSB), Health Resources and Services
Administration (HRSA), Room 11C–26,
5600 Fishers Lane, Rockville, Maryland
20857 or e-mail: djones2@hrsa.gov.
Requests should contain the name,
address, telephone number, and any
business or professional affiliation of
the person desiring to make an oral
presentation. Groups having similar
interests are requested to combine their
comments and present them through a
single representative. The allocation of
time may be adjusted to accommodate
the level of expressed interest. DVIC
will notify each presenter by mail or
telephone of their assigned presentation
time. Persons who do not file an
advance request for a presentation, but
desire to make an oral statement, may
announce it at the time of the comment
period. These persons will be allocated
time as it permits.
FOR FURTHER INFORMATION CONTACT:
Anyone requiring information regarding
the ACCV should contact LCDR Delia
Jones, Principal Staff Liaison, DVIC,
HSB, HRSA, Room 11C–26, 5600
Fishers Lane, Rockville, MD 20857;
telephone (301) 443–6593 or e-mail:
djones2@hrsa.gov.
Dated: May 11, 2007.
Caroline Lewis,
Associate Administrator for Management.
[FR Doc. E7–9533 Filed 5–17–07; 8:45 am]
pwalker on PROD1PC71 with NOTICES
BILLING CODE 4165–15–P
VerDate Aug<31>2005
17:06 May 17, 2007
Jkt 211001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
C.W. Bill Young Cell Transplantation
Program: National Cord Blood
Inventory Related Cord Blood Donor
Demonstration Project
Health Resources and Services
Administration (HRSA), HHS.
ACTION: Request for information.
AGENCY:
Public Law 109–129 requires
the Secretary of Health and Human
Services to establish a 3-year
demonstration project for qualified cord
blood banks to collect and store at no
charge to families, umbilical cord blood
units for families where a first-degree
relative has been diagnosed with a
condition that may benefit from blood
stem cell transplantation. Umbilical
cord blood units collected through the
demonstration project do not count
toward the current National Cord Blood
Inventory (NCBI) goal of 150,000 cord
blood units to be made available
through the C.W. Bill Young Cell
Transplantation Program. Qualified
umbilical cord blood banks
participating in the demonstration
project must provide assurances that the
cord blood units will be available for
directed transplantation until such time
as the cord blood unit is needed. Within
90 days of the termination of the
demonstration project, the Secretary
will submit to Congress a report on the
outcomes of the project including
recommendations with respect to the
continuation of such a project.
HRSA’s Healthcare Systems Bureau
(HSB), Division of Transplantation
(DoT) is in the process of informationgathering to assist in implementation of
the related cord blood demonstration
project. The purpose of this solicitation
is to receive public input on the
following: (1) The key questions that
should be studied through this project;
(2) the mechanism for funding this
project; and, (3) umbilical cord blood
bank liability.
HRSA has identified the following
key study questions to be considered in
the design of this demonstration project:
(1) What is the value and feasibility of
implementing a long-term program
modeled after this demonstration
project; (2) how often and for what
clinical indications are cord blood units
banked through this project used for
transplantation; (3) what is the
breakdown of cord blood units
collected, stored, and transplanted by
race, ethnicity, and disease; (4) do those
SUMMARY:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
28063
cord blood units, especially those
released for transplant, represent rare
Human Leukocyte Antigen (HLA) types
such that the recipient would otherwise
have been unable to find a matched
unrelated donor; (5) how do transplant
outcomes using these cord blood units
compare to unrelated allogeneic
umbilical cord blood transplants and
unrelated allogeneic transplants using
blood stem cells from adult donors; and,
(6) what are the general physical
characteristics of these units (e.g., total
nucleated count, CD34+ content) and
how does their quality compare to that
of the general public inventory.
HRSA proposes to invite the first
cohort of umbilical cord blood banks
receiving NCBI contracts to submit
competitive proposals for participation
in this demonstration project with an
emphasis on: (1) Establishment of
nationwide collections; and, (2)
encouraging banks to subcontract with
other experienced, high-quality cord
blood banks to assist in their education,
collection, processing, and storing
efforts. HRSA has approximately
$200,000 available for this
demonstration project this fiscal year
and anticipates selecting 2 or 3 banks to
participate in this demonstration project
to be funded through modification of
their existing NCBI contracts with
HRSA.
HRSA recognizes the need for this
service is likely greater than what can be
satisfied in a limited demonstration
project. Because of the great diversity in
HLA types among African-Americans,
HRSA recognizes that patients from this
population are significantly less likely
to find a suitably matched unrelated
blood stem cell donor than patients
from other racial or ethnic groups.
Therefore, HRSA invites comments on
the desirability of limiting participation
to African-American families in which a
first-degree relative has been diagnosed
with a condition that may benefit from
blood stem cell transplantation.
HRSA understands that there may be
special considerations associated with
liability for those umbilical cord blood
banks participating in this project.
HRSA invites comment on how
umbilical cord blood banks
participating in this project may best
address these concerns.
Interested parties are invited to
submit written comments on the key
study questions, the funding approach,
and umbilical cord blood bank liability
for this demonstration project to the
address below.
DATES: Written comments must be
received at HRSA by June 18, 2007.
Comments will be made publicly
E:\FR\FM\18MYN1.SGM
18MYN1
]]>Agencies
[Federal Register Volume 72, Number 96 (Friday, May 18, 2007)]
[Notices]
[Pages 28062-28063]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Commission on Childhood Vaccines; Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Public Law 92-463), notice is hereby given of the
following meeting:
Name: Advisory Commission on Childhood Vaccines (ACCV).
Date And Time: June 7, 2007, 1 p.m.--5 p.m., EST.
Place: (Audio Conference Call).
The ACCV will meet on Thursday, June 7, from 1 p.m. to 5 p.m.,
(EST). The public can join the meeting via audio conference call by
dialing 1-888-324-8527 on June 7 and providing the following
information:
Leader's Name: Dr. Geoffrey Evans.
Password: ACCV.
Agenda: The agenda items for the June meeting will include, but are
not limited to: a summary of the ``Vaccine
[[Page 28063]]
Safety Evaluation: Post-Marketing Surveillance'' conference; and
updates from the Division of Vaccine Injury Compensation (DVIC),
Department of Justice, National Vaccine Program Office, Immunization
Safety Office (Centers for Disease Control and Prevention), National
Institute of Allergy and Infectious Diseases (National Institutes of
Health), and Center for Biologics and Evaluation Research (Food and
Drug Administration). Agenda items are subject to change as priorities
dictate.
Public Comments: Persons interested in providing an oral
presentation should submit a written request, along with a copy of
their presentation to: LCDR Delia Jones, Principal Staff Liaison, DVIC,
Healthcare Systems Bureau (HSB), Health Resources and Services
Administration (HRSA), Room 11C-26, 5600 Fishers Lane, Rockville,
Maryland 20857 or e-mail: djones2@hrsa.gov. Requests should contain the
name, address, telephone number, and any business or professional
affiliation of the person desiring to make an oral presentation. Groups
having similar interests are requested to combine their comments and
present them through a single representative. The allocation of time
may be adjusted to accommodate the level of expressed interest. DVIC
will notify each presenter by mail or telephone of their assigned
presentation time. Persons who do not file an advance request for a
presentation, but desire to make an oral statement, may announce it at
the time of the comment period. These persons will be allocated time as
it permits.
FOR FURTHER INFORMATION CONTACT: Anyone requiring information regarding
the ACCV should contact LCDR Delia Jones, Principal Staff Liaison,
DVIC, HSB, HRSA, Room 11C-26, 5600 Fishers Lane, Rockville, MD 20857;
telephone (301) 443-6593 or e-mail: djones2@hrsa.gov.
Dated: May 11, 2007.
Caroline Lewis,
Associate Administrator for Management.
[FR Doc. E7-9533 Filed 5-17-07; 8:45 am]
BILLING CODE 4165-15-P
